Human Serum Albumin-Lipid Nanocapsules of Duvelisib for Hematological Cancers: Characterization, In-Vitro Cell-Culture, Toxicity and Pharmacokinetic Studies
Fields of Study & Subjects
Nanoparticle-Based Drug Delivery
Protein Degradation and Inhibitors
Lipid Membrane Structure and Behavior
Publication details
- Journal / source
- AAPS PharmSciTech
- Publisher
- Springer Science and Business Media LLC
- Volume
- 27
- Issue
- 1
- Pages
- 75–75
- Publication date
- 15 January 2026
- Language
- EN